中国患者交感性眼炎与Vogt-Koyanagi-Harada病的临床特征及视力结局比较
回顾性分析131例交感性眼炎(SO)与500例Vogt-Koyanagi-Harada(VKH)病患者,比较临床特征与视力结局。SO眼外表现频率低于VKH(24.4% vs 84.8%,P<0.001),治疗后SO最佳矫正视力差于VKH(P=0.003),SO有用视力丧失风险显著高于VKH(P<0.001)。
要点
- SO眼外表现频率24.4%,低于VKH的84.8%(P<0.001)。
- 随访12个月SO最佳矫正视力从0.68±0.86改善至0.47±0.78 logMAR(P=0.01),VKH从0.67±0.79改善至0.24±0.53 logMAR(P<0.001)。
- SO治疗后最佳矫正视力差于VKH(P=0.003),有用视力丧失风险显著高于VKH(P<0.001)。
核心结论
- 中国SO与VKH病患者具有不同的演变过程。
- SO患者眼外表现频率远低于VKH病患者。
- SO视力结局较VKH病差。
研究设计与样本
- 回顾性病例系列。
- 纳入2008年4月至2018年6月转诊至本葡萄膜炎中心的131例连续SO患者和随机选取的500例VKH病患者。
- 回顾性分析病史、眼外及眼部检查、最佳矫正视力、辅助检查、并发症和治疗效果。
主要发现
- SO在发病2周内表现为后葡萄膜炎(68.8%),发病2周至2个月之间前节和后节受累比例相等(44.4%)。
- SO发病2个月后表现为落日样眼底(51.2%)和肉芽肿性前葡萄膜炎(27.3%)。
- VKH病在上述三个时期主要表现为后葡萄膜炎(100%)、前节受累伴后葡萄膜炎(92.4%与84.9%)以及肉芽肿性前葡萄膜炎伴落日样眼底(97.4%与91.5%)。
- SO患者眼外表现频率为24.4%,低于VKH病患者的84.8%(P<0.001)。
- 随访12个月,SO患者最佳矫正视力从0.68±0.86 logMAR改善至0.47±0.78 logMAR(P=0.01),VKH病患者从0.67±0.79 logMAR改善至0.24±0.53 logMAR(P<0.001)。
关键数值与推荐
- SO患者治疗后最佳矫正视力差于VKH病患者(P=0.003)。
- Kaplan-Meier生存分析显示SO患者有用视力丧失风险显著高于VKH病患者(P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To characterize the clinical features of sympathetic ophthalmia (SO) and compare SO and Vogt-Koyanagi-Harada (VKH) disease in Chinese patients. DESIGN: Retrospective case series. PARTICIPANTS: A total of 131 consecutive SO and 500 VKH disease patients randomly selected from among those referred to our uveitis center from April 2008 through June 2018. METHODS: History, extraocular and ocular findings, best-corrected visual acuity (BCVA), auxiliary examination findings, complications, and therapeutic effects were analyzed retrospectively in SO and VKH disease patients. MAIN OUTCOME MEASURES: Visual outcome, extraocular and ocular findings, and therapeutic effects. RESULTS: Sympathetic ophthalmia manifested as posterior uveitis (68.8%) within 2 weeks and equal involvement of anterior and posterior segment (44.4%), respectively, was observed between 2 weeks and 2 months after disease onset. Two months after disease onset, SO patients showed sunset glow fundus (51.2%) and granulomatous anterior uveitis (27.3%). Vogt-Koyanagi-Harada disease patients mainly showed posterior uveitis (100%), anterior segment involvement (92.4%) associated with posterior uveitis (84.9%), and granulomatous anterior uveitis (97.4%) accompanying sunset glow fundus (91.5%) in the 3 periods mentioned above. The frequencies of extraocular manifestations were lower in SO patients (24.4%) as compared with VKH disease patients (84.8%; P < 0.001). Best-corrected visual acuity of SO patients improved from 0.68±0.86 logarithm of the minimum angle of resolution (logMAR) to 0.47±0.78 logMAR (P = 0.01), and BCVA of VKH disease patients improved from 0.67±0.79 logMAR to 0.24±0.53 logMAR (P < 0.001) at 12 months of follow-up. A worse BCVA was noted in SO patients compared with VKH disease patients after treatment (P = 0.003). Kaplan-Meier survival analysis showed that the risk of loss of useful vision in SO patients was significantly higher than that of VKH disease patients (P < 0.001). CONCLUSIONS: Chinese SO and VKH disease patients have a different evolutionary process. The frequency of extraocular manifestations in SO patients is much lower as compared with VKH disease patients. Visual outcome is worse in SO as compared with VKH disease.
引用
- Yang P, Liu S, Zhong Z, et al. Comparison of Clinical Features and Visual Outcome between Sympathetic Ophthalmia and Vogt-Koyanagi-Harada Disease in Chinese Patients. Ophthalmology. 2019. PMID: 30959067. doi:10.1016/j.ophtha.2019.03.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。